CMHC 2014 Symposium: Improving Awareness and Outcomes in Lipodystrophy Syndromes

This webcast will discuss the signs and symptoms of lipodystrophy, a rare disorder characterized by selective loss of adipose tissue. If not adequately treated, patients with lipodystrophy remain at risk for severe life-threatening complications and chronic morbidity, such as pancreatitis, end-stage liver or renal disease, accelerated atherosclerosis, and cardiomyopathy. The faculty will explain the metabolic consequences of the disease and present evidence-based treatment recommendations. A Lipodystrophy United Patient Advocate will provide the unique perspective of an individual living with the disease.

Supported by an educational grant from AstraZeneca

Understanding of the Physiologic Role of Adipose Tissue

Faculty: Abhimanyu Garg, MD

Identification, Diagnosis, and Metabolic Consequences of Lipodystrophy

Faculty: Elif A. Oral, MD

Novel Strategies for the Management of Lipodystrophy and its Metabolic Complications

Faculty: Rebecca J. Brown, MD

The Faces of Lipodystrophy: A Call to Action

Sponsored by Lipodystrophy United

Faculty: Andra Stratton

Exploring Synergistic Approaches to Improve Metabolic Complications in a Person with Lipodystrophy: Interactive, Case-Based Scenarios, Panel Discussion and Debate along with Audience Q&A

Moderator: Abhimanyu Garg, MD

Discussants: Rebecca J. Brown, MDElif A. Oral, MDAndra Stratton